Parkinsonian syndromes
- PMID: 24092286
- PMCID: PMC4234134
- DOI: 10.1212/01.CON.0000436152.24038.e0
Parkinsonian syndromes
Abstract
Purpose of review: The different parkinsonian conditions can be challenging to separate clinically. This review highlights the important clinical features that guide the diagnosis of Parkinson disease (PD), progressive supranuclear palsy (PSP), multiple system atrophy (MSA), and corticobasal degeneration (CBD). Strategies for treatment and disease management are also discussed.
Recent findings: Over the past decade there has been an increasing recognition of the broad clinical presentations of the neurodegenerative forms of parkinsonism. Nonmotor symptoms in these diseases, including psychiatric, cognitive, autonomic, and gastrointestinal dysfunction, appear to have a major impact on quality of life and disability. PSP and CBD are now considered pathologic diagnoses, with several different and varied clinical phenotypes, that overlap and share features with PD and frontotemporal dementia syndromes. PD is distinguished by its excellent response to dopaminergic medications that is maintained over many years, in contrast to the response seen in patients with MSA and PSP. New diagnostic criteria have been proposed for CBD. No new therapeutic interventions have emerged for PSP, MSA, or CBD. Infusional therapies and deep brain stimulation surgery are established therapies for advanced PD.
Summary: The "parkinsonian syndromes" encompass a number of nosologic entities that are grouped together on the basis of their shared clinical features but are separated on the basis of their different pathologies. Overall, the consideration of clinical signs, mode of disease onset, and nature of disease progression are all important to make a timely and definitive diagnosis.
Figures
![Figure 1-1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4234134/bin/8FF1.gif)
![Figure 1-2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4234134/bin/8FF2.gif)
![Figure 1-3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4234134/bin/8FF3.gif)
![Figure 1-4](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4234134/bin/8FF4.gif)
![Figure 1-5](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4234134/bin/8FF5.gif)
Similar articles
-
Diagnostic Approach to Atypical Parkinsonian Syndromes.Continuum (Minneap Minn). 2016 Aug;22(4 Movement Disorders):1117-42. doi: 10.1212/CON.0000000000000348. Continuum (Minneap Minn). 2016. PMID: 27495201 Free PMC article. Review.
-
Nonmotor Features in Atypical Parkinsonism.Int Rev Neurobiol. 2017;134:1285-1301. doi: 10.1016/bs.irn.2017.06.001. Epub 2017 Jul 3. Int Rev Neurobiol. 2017. PMID: 28805573 Review.
-
PSP as distinguished from CBD, MSA-P and PD by clinical and imaging differences at an early stage.Intern Med. 2011;50(22):2775-81. doi: 10.2169/internalmedicine.50.5954. Epub 2011 Nov 15. Intern Med. 2011. PMID: 22082889
-
The evolution of diagnosis from symptom onset to death in progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) compared to Parkinson's disease (PD).J Neurol. 2023 Jul;270(7):3464-3474. doi: 10.1007/s00415-023-11629-x. Epub 2023 Mar 27. J Neurol. 2023. PMID: 36971841 Free PMC article.
-
Lower urinary tract dysfunction in Parkinsonian syndromes.Neurol Sci. 2021 Oct;42(10):4045-4054. doi: 10.1007/s10072-021-05411-y. Epub 2021 Jul 28. Neurol Sci. 2021. PMID: 34318363 Review.
Cited by
-
Non-Motor Disorders in Parkinson Disease and Other Parkinsonian Syndromes.Medicina (Kaunas). 2024 Feb 11;60(2):309. doi: 10.3390/medicina60020309. Medicina (Kaunas). 2024. PMID: 38399596 Free PMC article.
-
Beyond traditional training: Integrating data from semi-immersive VR dual-task intervention in Parkinsonian Syndromes. A study protocol.PLoS One. 2024 Feb 1;19(2):e0294199. doi: 10.1371/journal.pone.0294199. eCollection 2024. PLoS One. 2024. PMID: 38300977 Free PMC article.
-
Free water imaging in Parkinson's disease and atypical parkinsonian disorders.J Neurol. 2024 May;271(5):2521-2528. doi: 10.1007/s00415-024-12184-9. Epub 2024 Jan 24. J Neurol. 2024. PMID: 38265472
-
Left and right corticobasal syndrome: comparison of cognitive profiles between metabolic imaging - matched groups.Neurol Sci. 2024 Apr;45(4):1499-1506. doi: 10.1007/s10072-023-07148-2. Epub 2023 Oct 27. Neurol Sci. 2024. PMID: 37889380 Free PMC article.
-
Optical coherence tomography angiography measurements in Parkinson's disease: A systematic review and meta-analysis.Eye (Lond). 2023 Oct;37(15):3145-3156. doi: 10.1038/s41433-023-02483-2. Epub 2023 Mar 20. Eye (Lond). 2023. PMID: 36941403 Review.
References
-
- Lim SY, Lang AE. The nonmotor symptoms of Parkinson’s disease-an overview. Mov Disord 2010; (25 suppl 1): S123– S130. - PubMed
-
- Williams DR, Lees AJ. How do patients with parkinsonism present? A clinicopathological study. Intern Med J 2009; 31 (1): 7– 12. - PubMed
-
- Deuschl G, Bain P, Brin M. Consensus statement of the Movement Disorder Society on Tremor. Ad Hoc Scientific Committee. Mov Disord 1998; (13 suppl 3): 2– 23. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous